NF-Y is necessary for hematopoietic stem cell proliferation and survival

Blood

Volumn 119, Issue 6, 2012, Pages 1380-1389

  Bungartz, Gerd ^a,b,c,d   Land, Hannah ^b   Scadden, David T ^c,d   Emerson, Stephen G ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HAVERFORD COLLEGE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Harvard University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; NOTCH1 RECEPTOR; NUCLEAR FACTOR Y; P21 ACTIVATED KINASE; PROTEIN BCL 2; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW DEPRESSION; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DEATH; FEMALE; GENE CONTROL; HEMATOPOIETIC STEM CELL; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

EID: 84856877564     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-06-359406     Document Type: Article

References (38)

1. Antonchuk J, Sauvageau G, Humphries RK. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell. 2002;109(1):39-45.
2. Bjornsson JM, Larsson N, Brun AC, et al. Reduced proliferative capacity of hematopoietic stem cells deficient in Hoxb3 and Hoxb4. Mol Cell Biol. 2003;23(11):3872-3883. (Pubitemid 36597466)
3. Brun AC, Bjornsson JM, Magnusson M, et al. Hoxb4-deficient mice undergo normal hematopoietic development but exhibit a mild proliferation defect in hematopoietic stem cells. Blood. 2004; 103(11):4126-4133. (Pubitemid 38685353)
4. Hadland BK, Huppert SS, Kanungo J, et al. A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development. Blood. 2004;104(10):3097-3105. (Pubitemid 39507124)
5. Hosen N, Yamane T, Muijtjens M, Pham K, Clarke MF,Weissman IL. Bmi-1-green fluorescent protein-knock-in mice reveal the dynamic regulation of bmi-1 expression in normal and leukemic hematopoietic cells. Stem Cells. 2007;25(7):1635-1644. (Pubitemid 47121840)
6. Iwama A, Oguro H, Negishi M, et al. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity. 2004;21(6):843-851. (Pubitemid 39626674)
7. Kumano K, Chiba S, Kunisato A, et al. Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. Immunity. 2003;18(5):699-711. (Pubitemid 36588586)
8. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 2003;423(6937):255-260. (Pubitemid 40852690)
9. Panepucci RA, Oliveira LH, Zanette DL, et al. Increased levels of NOTCH1, NF-kappaB, and other interconnected transcription factors characterize primitive sets of hematopoietic stem cells. Stem Cells Dev. 2010;19(3):321-332.
10. Staal FJ, Clevers HC. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol. 2005;5(1):21-30. (Pubitemid 40070328)
11. Stier S, Cheng T, Dombkowski D, Carlesso N, Scadden DT. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood. 2002;99(7):2369-2378. (Pubitemid 34525422)
12. van derWath RC, WilsonA, Laurenti E, TrumppA, Lio P. Estimating dormant and active hematopoietic stem cell kinetics through extensive modeling of bromodeoxyuridine label-retaining cell dynamics. PLoS One. 2009;4(9):e6972.
13. Bowie MB, McKnight KD, Kent DG, McCaffrey L, Hoodless PA, Eaves CJ. Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect. J Clin Invest. 2006;116(10):2808-2816. (Pubitemid 44511644)
14. Gomei Y, Nakamura Y, Yoshihara H, et al. Functional differences between two Tie2 ligands, angiopoietin- 1 and -2, in regulation of adult bone marrow hematopoietic stem cells. Exp Hematol. 2009;38(2):82-89.
15. Mantovani R. The molecular biology of the CCAAT-binding factor NF-Y. Gene. 1999;239(1): 15-27. (Pubitemid 29462565)
16. Bucher P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J Mol Biol. 1990;212(4):563-578.
17. Mantovani R. A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res. 1998;26(5): 1135-1143. (Pubitemid 28291681)
18. Zhu J, Giannola DM, Zhang Y, Rivera AJ, Emerson SG. NF-Y cooperates with USF1/2 to induce the hematopoietic expression of HOXB4. Blood. 2003;102(7):2420-2427. (Pubitemid 37193578)
19. Benatti P, Basile V, Merico D, Fantoni LI, Tagliafico E, Imbriano C. A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response. Nucleic Acids Res. 2008;36(5):1415-1428. (Pubitemid 351426096)
20. Hu Q, Lu JF, Luo R, Sen S, Maity SN. Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle. Nucleic Acids Res. 2006;34(21):6272-6285. (Pubitemid 44942748)
21. Bolognese F, Wasner M, Dohna CL, et al. The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated. Oncogene. 1999;18(10):1845-1853. (Pubitemid 29145852)
22. Caretti G, Salsi V, Vecchi C, Imbriano C, Mantovani R. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J Biol Chem. 2003;278(33):30435-30440. (Pubitemid 36994546)
23. Farina A, Manni I, Fontemaggi G, et al. Downregulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex. Oncogene. 1999;18(18):2818-2827. (Pubitemid 29250871)
24. Manni I, Mazzaro G, Gurtner A, et al. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J Biol Chem. 2001;276(8):5570-5576.
25. Bhattacharya A, Deng JM, Zhang Z, Behringer R, de Crombrugghe B, Maity SN. The B subunit of the CCAAT box binding transcription factor complex (CBF/NF-Y) is essential for early mouse development and cell proliferation. Cancer Res. 2003;63(23):8167-8172. (Pubitemid 37549464)
26. Zhu J, Zhang Y, Joe GJ, Pompetti R, Emerson SG. NF-Ya activates multiple hematopoietic stem cell (HSC) regulatory genes and promotes HSC selfrenewal. Proc Natl Acad Sci U S A. 2005;102(33): 11728-11733. (Pubitemid 41170794)
27. Domashenko AD, Danet-Desnoyers G, Aron A, Carroll MP, Emerson SG. TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells. Blood. 2010; 116(15):2676-2683.
28. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science. 1995; 269(5229):1427-1429.
29. Bungartz G, Stiller S, Bauer M, et al. Adult murine hematopoiesis can proceed without beta1 and beta7 integrins. Blood. 2006;108(6):1857-1864. (Pubitemid 44394994)
30. Dzierzak E, Medvinsky A, de Bruijn M. Qualitative and quantitative aspects of haematopoietic cell development in the mammalian embryo. Immunol Today. 1998;19(5):228-236. (Pubitemid 28275575)
31. Wilson A, Laurenti E, Oser G, et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008;135(6):1118-1129.
32. Essers MA, Offner S, Blanco-Bose WE, et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature. 2009;458(7240):904-908.
33. Sato T, Onai N, Yoshihara H, Arai F, Suda T, Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med. 2009; 15(6):696-700.
34. Radomska HS, Satterthwaite AB, Taranenko N, Narravula S, Krause DS, Tenen DG. A nuclear factor Y (NFY) site positively regulates the human CD34 stem cell gene. Blood. 1999;94(11): 3772-3780.
35. Gartel AL. p21(WAF1/CIP1) and cancer: a shifting paradigm? Biofactors. 2009;35(2):161-164.
36. Di Agostino S, Strano S, Emiliozzi V, et al. Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation. Cancer Cell. 2006;10(3):191-202. (Pubitemid 44311070)
37. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet. 2001;29(4):418-425. (Pubitemid 34326692)
38. Reya T. Regulation of hematopoietic stem cell self-renewal. Recent Prog Horm Res. 2003;58: 283-295. (Pubitemid 37339314)